NACDS and the Texas Federation of Drug Stores submitted three joint letters to the House Select Committee on Statewide Health Care Costs providing extensive comments on all three issues: (1) primary drivers of increased health care costs in Texas, (2) opportunities to better coordinate how public dollars are spent on health care, and (3) identify emerging and proven delivery system improvements and sustainable financing models that could reduce the cost of health care.
Also in Texas. The Board of Pharmacy, partnering with the Drug Enforcement Administration (DEA) Diversion Control Division, is hosting a virtual opioid symposium on both October 11 and 12, 2020. For information about speakers, program details, and registration information, visit here. The symposium offers three (3) hours (0.3 CEUs) of CE approved by the Texas State Board of Pharmacy for license renewal. This program may be counted toward the requirement of prescribing and monitoring controlled substances as outlined by Board rule 295.8 for pharmacists and toward Texas-specific pharmacy laws or rules for pharmacy technicians per Board rule 297.8
For more information, contact NACDS’ Mary Staples at 817-442-1155.